Glisson’s capsule blistering after hyperthermic intraperitoneal chemotherapy
Journal Title: Annals of Hepatology - Year 2012, Vol 11, Issue 1
Abstract
Hypertermic intraperitoneal chemotherapy is a treatment option after cytorreduction of certain types of malignancies with peritoneal spread. Blistering of the Glisson’s capsule has not been previously reported as a consequence of this treatment modality. Patient do not experiment any associated morbidity.
Authors and Affiliations
Heriberto Medina-Franco, Daniel Zamora-Valdés, Ariadne Sánchez-Ramón, Gabriela Trejo-Gómez
Keywords
Related Articles
- EP ID EP78109
- DOI -
- Views 162
- Downloads 0
Percutaneous ethanol injection before liver transplantation in the hepatocellular carcinoma
Background/objectives. The study evaluates the outcome of patients who performed orthotopic liver transplantation (LT) as treatment for hepatocellular carcinoma (HCC), with percutaneous ethanol injection (PEI) while on t...
Nonalcoholic fatty liver disease and its association with cardiovascular disease
An association between non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease (CVD) has been recently suggested. Indeed, different studies have demonstrated that NAFLD patients present increased subclinical...
An update on the management of hepatitis C: guidelines for protease inhibitor-based triple therapy from the Latin American Association for the Study of the Liver
Hepatitis C is a common cause of end-stage liver disease, and the main indication for liver transplantation in Latin America. Treatment of hepatitis C infected patients improves important long-term outcomes as mortality....
Hepatopulmonary syndrome: Is it time to redefine the MELD exception score for better organ allocation and outcomes?
Potential Molecular Targets of Statins in the Prevention of Hepatocarcinogenesis
Hepatocellular carcinoma (HCC) represents 90% of liver tumors. Statins, may reduce the incidence of various tumors, including HCC. Antitumoral activities may be mediated by changes in transforming growth factor-beta (TGF...